These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 14272682)

  • 1. Complex task to estimate immune responses to various poliovirus vaccines and vaccination schedules.
    Zaman K; Anand A
    Lancet Infect Dis; 2019 Oct; 19(10):1043-1045. PubMed ID: 31350191
    [No Abstract]   [Full Text] [Related]  

  • 2. [MASS IMMUNIZATION OF THE POPULATION WITH LIVE VACCINE AGAINST POLIOMYELITIS IN THE UKRAINE AND ITS EPIDEMIOLOGIC EFFECTIVENESS].
    LESHCHENKO PD; SINIAK KM
    Pediatr Akus Ginekol; 1964; 4():14-6. PubMed ID: 14294004
    [No Abstract]   [Full Text] [Related]  

  • 3. [DYNAMICS OF RISE IN THE TITER OF NEUTRALIZING ANTIBODIES IN CHILDREN VACCINATED WITH SABIN'S LIQUID DRIED TRIVALENT ANTIPOLIOMYELITIS VACCINE IN THE BAISUN REGION OF THE SURKHANDAR'IN AREA OF THE UZBEKISTAN SSR].
    ALIMUKHAMEDOV RK
    Med Zh Uzb; 1963 Jul; 8():55-60. PubMed ID: 14081025
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of Salk vaccine use in Delaware.
    HUDSON FI
    Del State Med J; 1956 Sep; 28(9):215-6. PubMed ID: 13365302
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences in the production of formalinized poliomyelitis vaccine on an industrial scale].
    ROKUTANDA T; UENO N; NONAKA S; TAKESHITA M; YAMAMOTO M; YOSHIKAWA H; TSUBOTA T; OGATA K
    Kumamoto Igakkai Zasshi; 1962 Nov; 36():800-14. PubMed ID: 13982511
    [No Abstract]   [Full Text] [Related]  

  • 6. 2022 Oral Abstract Presentation Schedule.
    Transfusion; 2022 Sep; 62 Suppl 2():1A-274A. PubMed ID: 36114600
    [No Abstract]   [Full Text] [Related]  

  • 7. Expert review on poliovirus immunity and transmission.
    Duintjer Tebbens RJ; Pallansch MA; Chumakov KM; Halsey NA; Hovi T; Minor PD; Modlin JF; Patriarca PA; Sutter RW; Wright PF; Wassilak SG; Cochi SL; Kim JH; Thompson KM
    Risk Anal; 2013 Apr; 33(4):544-605. PubMed ID: 22804479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response to oral poliovaccine in persons aged 16-18 years.
    Smith JW; Lee JA; Fletcher WB; Morris CA; Parker DA; Yetts R; Magrathe DI; Perkins FT
    J Hyg (Lond); 1976 Apr; 76(2):235-47. PubMed ID: 177700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New recommendations for poliovirus vaccination. Combination regimen captures best effects of available vaccines.
    Conrad DA; Jenson HB
    Postgrad Med; 1997 Nov; 102(5):45-8, 51-3, 59-60 passim. PubMed ID: 9385331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.
    Shimizu H
    Vaccine; 2016 Apr; 34(16):1975-85. PubMed ID: 25448090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RESPONSE TO ONE DOSE OF TRIVALENT ORAL POLIOVACCINE IN CHILDREN PREVIOUSLY IMMUNISED WITH SALK VACCINE: A COMPARISON OF LIQUID VACCINE AND A CAPSULE PRESENTATION.
    BEALE AJ; DAVIES JR; THROWER AL
    Lancet; 1965 Apr; 1(7391):879-81. PubMed ID: 14272682
    [No Abstract]   [Full Text] [Related]  

  • 12. FURTHER OBSERVATIONS ON VACCINATION IN INFANCY WITH ORAL POLIOMYELITIS VACCINE AND DIPHTHERIA, TETANUS, PERTUSSIS VACCINE.
    BUTLER NR; BENSON PF; URQUHART J; GOFFE AP; KNIGHT GJ; POLLOCK TM
    Br Med J; 1964 Aug; 2(5406):418-20. PubMed ID: 14160241
    [No Abstract]   [Full Text] [Related]  

  • 13. A DIPHTHERIA-TETANUS-POLIOMYELITIS VACCINE.
    DANE DS; DICK GW; HAIRE M; BRIGGS EM; CONNOR TJ
    Lancet; 1965 Apr; 1(7391):877-9. PubMed ID: 14272681
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. I. Vaccination with the WM3 strain in 20 families.
    Böttiger M; Lagercrantz R
    J Pediatr; 1969 Jul; 75(1):30-8. PubMed ID: 4307138
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.